Actinium Advisory Board Chairman to Participate in the Cancer Advance Boston: Focus on Innovation Conference at Harvard Medical School Sep 23, 2014
Actinium to Present at the 21st Annual BioCentury NewsMakers Conference on Friday, September 26th Sep 16, 2014
MD Anderson Department Chair Richard E. Champlin, M.D. Joins Actinium’s Iomab™-B Scientific Advisory Board Sep 10, 2014
Actinium Files Orphan Drug Application for Use of Actimab-A in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients Sep 3, 2014
Actinium to Present at the Rodman & Renshaw Annual Global Investment Conference on September 10th Aug 28, 2014
Actinium to Present at the Canaccord Genuity 34th Annual Growth Conference on August 13th Aug 5, 2014
Actinium Pharmaceuticals Provides Mid-Year Update Directed at Existing and Future Shareholders Aug 4, 2014
Baylor Sammons Cancer Center Joins as Clinical Trial Site for Actinium’s Actimab-A Clinical Trial Jul 30, 2014
CORRECTING and REPLACING Actinium Pharmaceuticals, Inc. Launches Development of Antibody Actinium-225 Labeling Construct To Support Third Clinical Program Jul 16, 2014